Techno Drugs (DHA:TECHNODRUG) Retained Earnings : BDT1,519 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Techno Drugs Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Techno Drugs's retained earnings for the quarter that ended in Dec. 2024 was BDT1,519 Mil.

Techno Drugs's quarterly retained earnings increased from Dec. 2023 (BDT0 Mil) to Sep. 2024 (BDT1,515 Mil) and increased from Sep. 2024 (BDT1,515 Mil) to Dec. 2024 (BDT1,519 Mil).

Techno Drugs Retained Earnings Historical Data

The historical data trend for Techno Drugs's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Techno Drugs Retained Earnings Chart

Techno Drugs Annual Data

Trend

Retained Earnings

Techno Drugs Quarterly Data
	Sep23	Dec23	Sep24	Dec24
Retained Earnings	-	-	1,515.02	1,519.10

Techno Drugs Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Techno Drugs (DHA:TECHNODRUG) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Techno Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Techno Drugs Ltd (DHA:TECHNODRUG) » Definitions » Retained Earnings

Traded in Other Exchanges

N/A

Address

31 Segun Bagicha, J K Tower, Dhaka, BGD, 1000

Website

https://www.technodrugsltd.com

Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.

Techno Drugs Headlines

No Headlines